Synonyms 胆囊收缩素A受体, CCK-A receptor, CCK-AR + [6] |
Introduction Receptor for cholecystokinin. Mediates pancreatic growth and enzyme secretion, smooth muscle contraction of the gall bladder and stomach. Has a 1000-fold higher affinity for CCK rather than for gastrin. It modulates feeding and dopamine-induced behavior in the central and peripheral nervous system. This receptor mediates its action by association with G proteins that activate a phosphatidylinositol-calcium second messenger system. |
Target |
Mechanism CCKA agonists [+1] |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication- |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc. US |
First Approval Date21 Jul 1976 |
Target |
Mechanism CCKA antagonists [+1] |
Active Org. |
Originator Org. |
Inactive Indication- |
Drug Highest PhasePhase 3 |
First Approval Ctry. / Loc.- |
First Approval Date20 Jan 1800 |
Target |
Mechanism CCKA antagonists |
Active Org. |
Originator Org. |
Active Indication |
Drug Highest PhasePhase 3 |
First Approval Ctry. / Loc.- |
First Approval Date20 Jan 1800 |
Start Date28 Oct 2022 |
Sponsor / Collaborator |
Start Date27 Sep 2021 |
Sponsor / Collaborator |
Start Date28 Oct 2020 |
Sponsor / Collaborator |